Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy

Analysis of a multi-institutional preclinical trial planning study

Yunfeng Cui, Wenzhou Chen, Feng Ming Kong, Lindsey A. Olsen, Ronald E. Beatty, Peter G. Maxim, Timothy Ritter, Jason W. Sohn, Jane Higgins, James M. Galvin, Ying Xiao

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: To quantify variations in target and normal structure contouring and evaluate dosimetric impact of these variations in non-small cell lung cancer (NSCLC) cases. To study whether providing an atlas can reduce potential variation. Methods and materials: Three NSCLC cases were distributed sequentially to multiple institutions for contouring and radiation therapy planning. No segmentation atlas was provided for the first 2 cases (Case 1 and Case 2). Contours were collected from submitted plans and consensus contour sets were generated. The volume variation among institution contours and the deviation of them from consensus contours were analyzed. The dose-volume histograms for individual institution plans were recalculated using consensus contours to quantify the dosimetric changes. An atlas containing targets and critical structures was constructed and was made available when the third case (Case 3) was distributed for planning. The contouring variability in the submitted plans of Case 3 was compared with that in first 2 cases. Results: Planning target volume (PTV) showed large variation among institutions. The PTV coverage in institutions' plans decreased dramatically when reevaluated using the consensus PTV contour. The PTV contouring consistency did not show improvement with atlas use in Case 3. For normal structures, lung contours presented very good agreement, while the brachial plexus showed the largest variation. The consistency of esophagus and heart contouring improved significantly (t test; P < .05) in Case 3. Major factors contributing to the contouring variation were identified through a survey questionnaire. Conclusions: The amount of contouring variations in NSCLC cases was presented. Its impact on dosimetric parameters can be significant. The segmentation atlas improved the contour agreement for esophagus and heart, but not for the PTV in this study. Quality assurance of contouring is essential for a successful multi-institutional clinical trial.

Original languageEnglish (US)
Pages (from-to)e67-e75
JournalPractical Radiation Oncology
Volume5
Issue number2
DOIs
StatePublished - Mar 1 2015

Fingerprint

Atlases
Non-Small Cell Lung Carcinoma
Radiotherapy
Esophagus
Brachial Plexus
Clinical Trials
Lung

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy : Analysis of a multi-institutional preclinical trial planning study. / Cui, Yunfeng; Chen, Wenzhou; Kong, Feng Ming; Olsen, Lindsey A.; Beatty, Ronald E.; Maxim, Peter G.; Ritter, Timothy; Sohn, Jason W.; Higgins, Jane; Galvin, James M.; Xiao, Ying.

In: Practical Radiation Oncology, Vol. 5, No. 2, 01.03.2015, p. e67-e75.

Research output: Contribution to journalArticle

Cui, Y, Chen, W, Kong, FM, Olsen, LA, Beatty, RE, Maxim, PG, Ritter, T, Sohn, JW, Higgins, J, Galvin, JM & Xiao, Y 2015, 'Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study', Practical Radiation Oncology, vol. 5, no. 2, pp. e67-e75. https://doi.org/10.1016/j.prro.2014.05.005
Cui, Yunfeng ; Chen, Wenzhou ; Kong, Feng Ming ; Olsen, Lindsey A. ; Beatty, Ronald E. ; Maxim, Peter G. ; Ritter, Timothy ; Sohn, Jason W. ; Higgins, Jane ; Galvin, James M. ; Xiao, Ying. / Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy : Analysis of a multi-institutional preclinical trial planning study. In: Practical Radiation Oncology. 2015 ; Vol. 5, No. 2. pp. e67-e75.
@article{48f87bf7b1224b76bbcf131780e37ee5,
title = "Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study",
abstract = "Purpose: To quantify variations in target and normal structure contouring and evaluate dosimetric impact of these variations in non-small cell lung cancer (NSCLC) cases. To study whether providing an atlas can reduce potential variation. Methods and materials: Three NSCLC cases were distributed sequentially to multiple institutions for contouring and radiation therapy planning. No segmentation atlas was provided for the first 2 cases (Case 1 and Case 2). Contours were collected from submitted plans and consensus contour sets were generated. The volume variation among institution contours and the deviation of them from consensus contours were analyzed. The dose-volume histograms for individual institution plans were recalculated using consensus contours to quantify the dosimetric changes. An atlas containing targets and critical structures was constructed and was made available when the third case (Case 3) was distributed for planning. The contouring variability in the submitted plans of Case 3 was compared with that in first 2 cases. Results: Planning target volume (PTV) showed large variation among institutions. The PTV coverage in institutions' plans decreased dramatically when reevaluated using the consensus PTV contour. The PTV contouring consistency did not show improvement with atlas use in Case 3. For normal structures, lung contours presented very good agreement, while the brachial plexus showed the largest variation. The consistency of esophagus and heart contouring improved significantly (t test; P < .05) in Case 3. Major factors contributing to the contouring variation were identified through a survey questionnaire. Conclusions: The amount of contouring variations in NSCLC cases was presented. Its impact on dosimetric parameters can be significant. The segmentation atlas improved the contour agreement for esophagus and heart, but not for the PTV in this study. Quality assurance of contouring is essential for a successful multi-institutional clinical trial.",
author = "Yunfeng Cui and Wenzhou Chen and Kong, {Feng Ming} and Olsen, {Lindsey A.} and Beatty, {Ronald E.} and Maxim, {Peter G.} and Timothy Ritter and Sohn, {Jason W.} and Jane Higgins and Galvin, {James M.} and Ying Xiao",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.prro.2014.05.005",
language = "English (US)",
volume = "5",
pages = "e67--e75",
journal = "Practical Radiation Oncology",
issn = "1879-8500",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy

T2 - Analysis of a multi-institutional preclinical trial planning study

AU - Cui, Yunfeng

AU - Chen, Wenzhou

AU - Kong, Feng Ming

AU - Olsen, Lindsey A.

AU - Beatty, Ronald E.

AU - Maxim, Peter G.

AU - Ritter, Timothy

AU - Sohn, Jason W.

AU - Higgins, Jane

AU - Galvin, James M.

AU - Xiao, Ying

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Purpose: To quantify variations in target and normal structure contouring and evaluate dosimetric impact of these variations in non-small cell lung cancer (NSCLC) cases. To study whether providing an atlas can reduce potential variation. Methods and materials: Three NSCLC cases were distributed sequentially to multiple institutions for contouring and radiation therapy planning. No segmentation atlas was provided for the first 2 cases (Case 1 and Case 2). Contours were collected from submitted plans and consensus contour sets were generated. The volume variation among institution contours and the deviation of them from consensus contours were analyzed. The dose-volume histograms for individual institution plans were recalculated using consensus contours to quantify the dosimetric changes. An atlas containing targets and critical structures was constructed and was made available when the third case (Case 3) was distributed for planning. The contouring variability in the submitted plans of Case 3 was compared with that in first 2 cases. Results: Planning target volume (PTV) showed large variation among institutions. The PTV coverage in institutions' plans decreased dramatically when reevaluated using the consensus PTV contour. The PTV contouring consistency did not show improvement with atlas use in Case 3. For normal structures, lung contours presented very good agreement, while the brachial plexus showed the largest variation. The consistency of esophagus and heart contouring improved significantly (t test; P < .05) in Case 3. Major factors contributing to the contouring variation were identified through a survey questionnaire. Conclusions: The amount of contouring variations in NSCLC cases was presented. Its impact on dosimetric parameters can be significant. The segmentation atlas improved the contour agreement for esophagus and heart, but not for the PTV in this study. Quality assurance of contouring is essential for a successful multi-institutional clinical trial.

AB - Purpose: To quantify variations in target and normal structure contouring and evaluate dosimetric impact of these variations in non-small cell lung cancer (NSCLC) cases. To study whether providing an atlas can reduce potential variation. Methods and materials: Three NSCLC cases were distributed sequentially to multiple institutions for contouring and radiation therapy planning. No segmentation atlas was provided for the first 2 cases (Case 1 and Case 2). Contours were collected from submitted plans and consensus contour sets were generated. The volume variation among institution contours and the deviation of them from consensus contours were analyzed. The dose-volume histograms for individual institution plans were recalculated using consensus contours to quantify the dosimetric changes. An atlas containing targets and critical structures was constructed and was made available when the third case (Case 3) was distributed for planning. The contouring variability in the submitted plans of Case 3 was compared with that in first 2 cases. Results: Planning target volume (PTV) showed large variation among institutions. The PTV coverage in institutions' plans decreased dramatically when reevaluated using the consensus PTV contour. The PTV contouring consistency did not show improvement with atlas use in Case 3. For normal structures, lung contours presented very good agreement, while the brachial plexus showed the largest variation. The consistency of esophagus and heart contouring improved significantly (t test; P < .05) in Case 3. Major factors contributing to the contouring variation were identified through a survey questionnaire. Conclusions: The amount of contouring variations in NSCLC cases was presented. Its impact on dosimetric parameters can be significant. The segmentation atlas improved the contour agreement for esophagus and heart, but not for the PTV in this study. Quality assurance of contouring is essential for a successful multi-institutional clinical trial.

UR - http://www.scopus.com/inward/record.url?scp=84924506563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924506563&partnerID=8YFLogxK

U2 - 10.1016/j.prro.2014.05.005

DO - 10.1016/j.prro.2014.05.005

M3 - Article

VL - 5

SP - e67-e75

JO - Practical Radiation Oncology

JF - Practical Radiation Oncology

SN - 1879-8500

IS - 2

ER -